Document ID: chunk:federal_register_of_legislation:F2022C00906:front:0:p5
Version: federal_register_of_legislation:F2022C00906
Segment Type: other
Provision Reference: 
Character Range: 11599–14631

for at least 5,000 hours; or
(b)          being exposed to second-hand smoke for at least 1,000 hours but less than 5,000 hours, and the clinical worsening of renal artery atherosclerotic disease has occurred within five years of the last exposure to second-hand smoke;
             Note: being exposed to second-hand smoke is defined in the Schedule 1 - Dictionary.
(24)      having hyperhomocysteinaemia before the clinical worsening of renal artery atherosclerotic disease;
(25)      an inability to undertake any physical activity greater than three METs for at least five years within the 20 years before the clinical worsening of renal artery atherosclerotic disease;
            Note: MET is defined in the Schedule 1 - Dictionary.
(26)      having chronic kidney disease for a period of at least five years before the clinical worsening of renal artery atherosclerotic disease;
            Note: chronic kidney disease is defined in the Schedule 1 - Dictionary.
(27)      undergoing a course of therapeutic radiation for cancer, where the renal artery was in the field of radiation, before the clinical worsening of renal artery atherosclerotic disease;
(28)      having received a cumulative equivalent dose of at least 0.5 sievert of ionising radiation to the renal artery before the clinical worsening of renal artery atherosclerotic disease;
            Note: cumulative equivalent dose is defined in the Schedule 1 - Dictionary.
(29)      an inability to consume an average of at least 100 grams per day of any combination of fruit and vegetables, for at least five consecutive years within the 20 years before the clinical worsening of renal artery atherosclerotic disease;
(30)      having periodontitis for at least the two years before the clinical worsening of renal artery atherosclerotic disease;
(31)      being treated with an angiotensin converting enzyme inhibitor or an angiotensin receptor blocker, within the three months before the clinical worsening of renal artery atherosclerotic disease;
(32)      inability to obtain appropriate clinical management for renal artery atherosclerotic disease.
     10           Relationship to service
(1)          The existence in a person of any factor referred to in section 9, must be related to the relevant service rendered by the person.
(2)          The factors set out in subsections 9(16) to 9(32) apply only to material contribution to, or aggravation of, renal artery atherosclerotic disease where the person's renal artery atherosclerotic disease was suffered or contracted before or during (but did not arise out of) the person's relevant service.
     11           Factors referring to an injury or disease covered by another Statement of Principles
In this Statement of Principles:
(1)          if a factor referred to in section 9 applies in relation to a person; and
(2)          that factor refers to an injury or disease in respect of which a Statement of Principles has been determined under subsection 196B(2) of the VEA;
then the factors in that